Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 11 results.
User Information
Export Records
  1. 1.   CENP-A overexpression promotes aneuploidy with karyotypic heterogeneity
  2. Shrestha, Roshan L.; Rossi, Austin; Wangsa, Darawalee; Hogan, Ann K.; Zaldana, Kimberly S.; Suva, Evelyn; Chung, Yang Jo; Sanders,Chelsea; Difilippantonio,Simone; Karpova, Tatiana S.; Karim,Baktiar; Foltz, Daniel R.; Fachinetti, Daniele; Aplan, Peter D.; Ried, Thomas; Basrai, Munira A.
  3. The Journal of Cell Biology. 2021, Feb 23; 220(4):
  1. 2.   GATA2 Deficiency: Early Identification for Improved Clinical Outcomes
  2. Cole, Kristen; Avila, Daniele; Parta,Mark; Schuver, Bazetta; Holland, Steven; Shah, Nirali; Hickstein, Dennis
  3. Clinical journal of oncology nursing. 2019, Aug 01; 23(4): 417-422.
  1. 3.   Allogeneic Hematopoietic Stem-Cell Transplantation for GATA2 Deficiency Using a Busulfan-Based Regimen
  2. Parta, Mark; Shah, Nirali N; Baird, Kristin; Rafei, Hind; Calvo, Katherine R; Hughes, Thomas; Cole, Kristen; Kenyon, Meg; Blacklock Schuver, Bazetta; Cuellar-Rodriguez, Jennifer; Zerbe, Christa S; Holland, Steven M; Hickstein, Dennis D
  3. Biology of Blood and Marrow Transplantation. 2018, Jun; 24(6): 1250-1259.
  1. 4.   2 '-deoxy-N4-[2-(4-nitrophenyl)ethoxycarbonyl]-5-azacytidine: A novel inhibitor of DNA methyltransferase that requires activation by human carboxylesterase
  2. Byun, H. M.; Choi, S. H.; Laird, P. W.; Trinh, B.; Siddiqui, M. A.; Marquez, V. E.; Yang, A. S.
  3. Cancer Letters. 2008 266(2): 238-248.
  1. 5.   Thalidomide analogues as anticancer drugs
  2. Aragon-Ching, J. B.; Li, H. Q.; Gardner, E. R.; Figg, W. D.
  3. Recent Patents on Anti-Cancer Drug Discovery. 2007, Jun; 2(2): 167-174.
  1. 6.   The novel DNA methylation inhibitor zebularine is effective against the development of murine T-cell lymphoma
  2. Herranz, M.; Martin-Caballero, J.; Fraga, M. F.; Ruiz-Cabello, J.; Flores, J. M.; Desco, M.; Marquez, V.; Esteller, M.
  3. Blood. 2006, FEB 1; 107(3): 1174-1177.
  1. 7.   Insertional mutagenesis identifies genes that promote the immortalization of primary bone marrow progenitor cells
  2. Du, Y.; Jenkins, N. A.; Copeland, N. G.
  3. Blood. 2005, DEC 1; 106(12): 3932-3939.
  1. 8.   In vitro selective suppression of feline myeloid colony formation is attributable to molecularly cloned strain of feline leukemia virus with unique long terminal repeat
  2. Nagashima, N.; Hisasue, M.; Nishigaki, K.; Miyazawa, T.; Kano, R.; Hasegawa, A.
  3. Research in Veterinary Science. 2005, APR; 78(2): 151-154.
  1. 9.   C/EBP alpha deficiency results in hyperproliferation of hematopoietic progenitor cells and disrupts macrophage development in vitro and in vivo
  2. Heath, V.; Suh, H. C.; Holman, M.; Renn, K.; Gooya, J. M.; Parkin, S.; Klarmann, K. D.; Ortiz, M.; Johnson, P.; Keller, J.
  3. Blood. 2004, SEP 15; 104(6): 1639-1647.
  1. 10.   Continuous zebularine treatment effectively sustains demethylation in human bladder cancer cells
  2. Cheng, J. C.; Weisenberger, D. J.; Gonzales, F. A.; Liang, G. N.; Xu, G. L.; Hu, Y. G.; Marquez, V. E.; Jones, P. A.
  3. Molecular and Cellular Biology. 2004 24(3): 1270-1278.
  1. 11.   Clonality analysis of various hematopoietic disorders in cats naturally infected with feline leukemia virus
  2. Hisasue, M.; Nishigaki, K.; Katae, H.; Yuri, K.; Mizuno, T.; Fujino, Y.; Setoguchi, A.; Hasegawa, A.; Watari, T.; Masuda, K.; Ohno, K.; Tsujimoto, H.
  3. Journal of Veterinary Medical Science. 2000 62(10): 1059-1065.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel